Back
Altimmune Vs. Xometry Industry Stock Comparison
Sell
47
ALT
Altimmune
Last Price:
7.30
Seasonality Move:
13.24%
Buy
60
XMTR
Xometry
Last Price:
30.62
Seasonality Move:
21.1%
Sell
47
Altimmune (ALT)
is a Sell
Is Altimmune a Buy, Sell or Hold?
- The current Altimmune [ALT] share price is $7.03. The Score for ALT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- ALT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Xometry (XMTR)
is a Buy
Is Xometry a Buy, Sell or Hold?
- The current Xometry [XMTR] share price is $25.84. The Score for XMTR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- XMTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 55.61 | Buy |
| Chaikin Money Flow: | 1672979 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.26 - 6.96) | Buy |
| Bollinger Bands (100): | (6.17 - 7.23) | Buy |
XMTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.14 | Buy |
| Relative Strength Index (14 RSI): | 76.63 | Buy |
| Chaikin Money Flow: | 752791 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.48 - 21.52) | Buy |
| Bollinger Bands (100): | (13.56 - 19.92) | Buy |
ALT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.89 | Buy |
| 20-day SMA: | 6.71 | Buy |
| 50-day SMA: | 6.77 | Buy |
| 200-day SMA: | 7.7 | Sell |
| 8-day EMA: | 6.86 | Buy |
| 20-day EMA: | 6.79 | Buy |
| 50-day EMA: | 6.75 | Buy |
| 200-day EMA: | 6.98 | Buy |
XMTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.19 | Buy |
| 20-day SMA: | 20.01 | Buy |
| 50-day SMA: | 19.15 | Buy |
| 200-day SMA: | 18.81 | Buy |
| 8-day EMA: | 21.9 | Buy |
| 20-day EMA: | 20.49 | Buy |
| 50-day EMA: | 19.11 | Buy |
| 200-day EMA: | 18.83 | Buy |
Altimmune Earnings Growth & ALT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and a decrease next year of $0.29 per share.
Xometry Earnings Growth & XMTR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.37 per share.
Altimmune Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xometry Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||